Free Trial
NASDAQ:PRCT

PROCEPT BioRobotics Q1 2025 Earnings Report

PROCEPT BioRobotics logo
$52.92 -0.84 (-1.56%)
Closing price 04/15/2025 04:00 PM Eastern
Extended Trading
$51.75 -1.17 (-2.21%)
As of 08:43 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PROCEPT BioRobotics EPS Results

Actual EPS
N/A
Consensus EPS
-$0.49
Beat/Miss
N/A
One Year Ago EPS
N/A

PROCEPT BioRobotics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

PROCEPT BioRobotics Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call Date
Thursday, April 24, 2025
Conference Call Time
8:00AM ET

Conference Call Resources

Remove Ads

PROCEPT BioRobotics Earnings Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Procept BioRobotics price target lowered to $70 from $90 at Truist
See More PROCEPT BioRobotics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like PROCEPT BioRobotics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PROCEPT BioRobotics and other key companies, straight to your email.

About PROCEPT BioRobotics

PROCEPT BioRobotics (NASDAQ:PRCT), a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

View PROCEPT BioRobotics Profile

More Earnings Resources from MarketBeat